ID
43573
Beskrivning
Study ID: 101468/197 Clinical Study ID: SKF-101468/197 Study Title:An open study to compare the PK and tolerability of ropinirole administered as 5 different new formulations with the standard, marketed formulation in healthy volunteers Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Requip Study Indication : Restless Legs Syndrome for internal use, not to be databased
Nyckelord
Versioner (3)
- 2017-09-12 2017-09-12 -
- 2017-09-12 2017-09-12 -
- 2021-09-20 2021-09-20 -
Uppladdad den
20 september 2021
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
visit period 1,2,3 & 4 baseline/adverse event checklist PK and tolerability of ropinirole as 5 new formulations 101468/197
visit period 1,2,3 & 4 baseline/adverse event checklist PK and tolerability of ropinirole as 5 new formulations 101468/197
Similar models
visit period 1,2,3 & 4 baseline/adverse event checklist PK and tolerability of ropinirole as 5 new formulations 101468/197
C3174092 (UMLS CUI [1,2])